help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YUAN, A.
Right arrow Articles by LUH, K.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YUAN, A.
Right arrow Articles by LUH, K.-T.

Am. J. Respir. Crit. Care Med., Volume 162, Number 5, November 2000, 1957-1963

Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non-Small-Cell Lung Cancer

ANG YUAN, PAN-CHYR YANG, CHONG-JEN YU, WEN-JONE CHEN, FANG-YUE LIN, SOW-HSONG KUO, and KWEN-TAY LUH

From the Departments of Internal Medicine, Surgery, and Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Tumor-associated angiogenesis is important for tumor growth and metastasis. Interleukin (IL)-8 was recently reported to be an important angiogenic factor both in vitro and in vivo. In this study we evaluated, for the first time, IL-8 messenger RNA (mRNA) expression in non-small-cell lung cancer (NSCLC), using real-time quantitative reverse-transcription-polymerase chain reaction, and correlated IL-8 mRNA expression in tumor and nontumor lung samples from 58 patients with NSCLC (29 with squamous cell carcinoma and 29 with adenocarcinoma, of whom 20 had Stage I, 10 had Stage II, and 28 had Stage III disease) with these patients' clinicopathologic characteristics, angiogenesis, and outcome. IL-8 protein expression and tumor microvessel count (MC) were assessed immunohistochemically. IL-8 mRNA expression was significantly greater in tumor tissue; high expression was highly associated with tumor in advanced stages (p = 0.03), distant lymph node metastasis (p = 0.02), high tumor MC (> 123) (p = 0.00003), short survival (< 26 mo) (p < 0.00001), and early relapse (< 16 mo) (p < 0.00001). Tumor MC correlated strongly with IL-8 mRNA expression (r = 0.56, p < 0.001). Multivariate analysis showed IL-8 mRNA expression and intratumor MC to be the most important predictors of patient survival and relapse. Thus, in NSCLC, IL-8 mRNA expression is strongly associated with tumor progression, tumor angiogenesis, survival, and time to relapse, suggesting its use as a prognostic indicator.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. Yanagawa, T. C. Walser, L. X. Zhu, L. Hong, M. C. Fishbein, V. Mah, D. Chia, L. Goodglick, D. A. Elashoff, J. Luo, et al.
Snail Promotes CXCR2 Ligand-Dependent Tumor Progression in Non-Small Cell Lung Carcinoma
Clin. Cancer Res., November 15, 2009; 15(22): 6820 - 6829.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
U. Grandel, D. Heygster, U. Sibelius, L. Fink, S. Sigel, W. Seeger, F. Grimminger, and K. Hattar
Amplification of Lipopolysaccharide-Induced Cytokine Synthesis in Non-Small Cell Lung Cancer/Neutrophil Cocultures
Mol. Cancer Res., October 1, 2009; 7(10): 1729 - 1735.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C.-Y. Lee, H.-F. Sher, H.-W. Chen, C.-C. Liu, C.-H. Chen, C.-S. Lin, P.-C. Yang, H.-S. Tsay, and J. J.W. Chen
Anticancer effects of tanshinone I in human non-small cell lung cancer
Mol. Cancer Ther., November 1, 2008; 7(11): 3527 - 3538.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
H. Sun, W.-C. Chung, S.-H. Ryu, Z. Ju, H. T. Tran, E. Kim, J. M. Kurie, and J. S. Koo
Cyclic AMP-Responsive Element Binding Protein- and Nuclear Factor-{kappa}B-Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis
Cancer Prevention Research, October 1, 2008; 1(5): 316 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Lurje, W. Zhang, A. M. Schultheis, D. Yang, S. Groshen, A. E. Hendifar, H. Husain, M. A. Gordon, F. Nagashima, H. M. Chang, et al.
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
Ann. Onc., October 1, 2008; 19(10): 1734 - 1741.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Wald, U. Izhar, G. Amir, S. Avniel, Y. Bar-Shavit, H. Wald, I. D. Weiss, E. Galun, and A. Peled
CD4+CXCR4highCD69+ T Cells Accumulate in Lung Adenocarcinoma
J. Immunol., November 15, 2006; 177(10): 6983 - 6990.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Wislez, N. Fujimoto, J. G. Izzo, A. E. Hanna, D. D. Cody, R. R. Langley, H. Tang, M. D. Burdick, M. Sato, J. D. Minna, et al.
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.
Cancer Res., April 15, 2006; 66(8): 4198 - 4207.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Liu and A. Deisseroth
Tumor vascular targeting therapy with viral vectors
Blood, April 15, 2006; 107(8): 3027 - 3033.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. W. Liu, S. T. Chen, and H. P. Liu
Choice of endogenous control for gene expression in nonsmall cell lung cancer
Eur. Respir. J., December 1, 2005; 26(6): 1002 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P.-L. Yao, Y.-C. Lin, C.-H. Wang, Y.-C. Huang, W.-Y. Liao, S.-S. Wang, J. J. W. Chen, and P.-C. Yang
Autocrine and Paracrine Regulation of Interleukin-8 Expression in Lung Cancer Cells
Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 540 - 547.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Singhal, A. Vachani, D. Antin-Ozerkis, L. R. Kaiser, and S. M. Albelda
Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non-Small Cell Lung Cancer: A Review
Clin. Cancer Res., June 1, 2005; 11(11): 3974 - 3986.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Vallbohmer, W. Zhang, M. Gordon, D. Y. Yang, J. Yun, O. A. Press, K. E. Rhodes, A. E. Sherrod, S. Iqbal, K. D. Danenberg, et al.
Molecular Determinants of Cetuximab Efficacy
J. Clin. Oncol., May 20, 2005; 23(15): 3536 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. J.W. Chen, Y.-C. Lin, P.-L. Yao, A. Yuan, H.-Y. Chen, C.-T. Shun, M.-F. Tsai, C.-H. Chen, and P.-C. Yang
Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression
J. Clin. Oncol., February 10, 2005; 23(5): 953 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Pold, L. X. Zhu, S. Sharma, M. D. Burdick, Y. Lin, P. P. N. Lee, A. Pold, J. Luo, K. Krysan, M. Dohadwala, et al.
Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer
Cancer Res., March 1, 2004; 64(5): 1853 - 1860.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-R. Kao, J.-Y. Shih, W.-C. Wen, Y.-P. Ko, B.-M. Chen, Y.-L. Chan, Y.-W. Chu, P.-C. Yang, C.-W. Wu, and S. R. Roffler
Tumor-associated Antigen L6 and the Invasion of Human Lung Cancer Cells
Clin. Cancer Res., July 1, 2003; 9(7): 2807 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. J.W. Chen, P.-L. Yao, A. Yuan, T.-M. Hong, C.-T. Shun, M.-L. Kuo, Y.-C. Lee, and P.-C. Yang
Up-Regulation of Tumor Interleukin-8 Expression by Infiltrating Macrophages: Its Correlation with Tumor Angiogenesis and Patient Survival in Non-Small Cell Lung Cancer
Clin. Cancer Res., February 1, 2003; 9(2): 729 - 737.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. S. White, K. R. Flaherty, S. Carskadon, A. Brant, M. D. Iannettoni, J. Yee, M. B. Orringer, and D. A. Arenberg
Macrophage Migration Inhibitory Factor and CXC Chemokine Expression in Non-Small Cell Lung Cancer: Role in Angiogenesis and Prognosis
Clin. Cancer Res., February 1, 2003; 9(2): 853 - 860.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. D. Brundage, D. Davies, and W. J. Mackillop
Prognostic Factors in Non-small Cell Lung Cancer* : A Decade of Progress
Chest, September 1, 2002; 122(3): 1037 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
N. Z. Khokhar, A. F. Y. Lam, V. W. Rusch, and F. M. Sirotnak
Despite some expression of folate receptor {alpha} in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated
J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 862 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Z. Khokhar, Y. She, V. W. Rusch, and F. M. Sirotnak
Experimental Therapeutics with a New 10-Deazaaminopterin in Human Mesothelioma: Further Improving Efficacy through Structural Design, Pharmacologic Modulation at the Level of MRP ATPases, and Combined Therapy with Platinums
Clin. Cancer Res., October 1, 2001; 7(10): 3199 - 3205.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J.-Y. Shih, S.-C. Yang, T.-M. Hong, A. Yuan, J. J. W. Chen, C.-J. Yu, Y.-L. Chang, Y.-C. Lee, K. Peck, C.-W. Wu, et al.
Collapsin Response Mediator Protein-1 and the Invasion and Metastasis of Cancer Cells
J Natl Cancer Inst, September 19, 2001; 93(18): 1392 - 1400.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. Papetti and I. M. Herman
Mechanisms of normal and tumor-derived angiogenesis
Am J Physiol Cell Physiol, May 1, 2002; 282(5): C947 - C970.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society 		  Red In Translatin